Anti-Human CD40L Therapeutic Antibody (Ruplizumab)
Recombinant monoclonal antibody to Human CD40L. Ruplizumab is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-027 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD40L |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods. |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |